Benzinga | Apr 27, 2021 10:37AM EDT

Adamas Pharmaceuticals Granted U.S. Patent Titled 'Methods and compositions for the treatment of seizure-related disorders'

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=adamas.AANM.&OS=AANM/adamas&RS=AANM/http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=adamas.AANM.&OS=AANM/adamas&RS=AANM/adamas